Medtronic officer proposes $1M share sale

Medtronic's common-stock outstanding count is listed as 1,279,137,890 shares.

Rhea-AI Filing Summary

Medtronic plc officer Michael Marinaro is listed for a proposed sale of 10,420 common shares, with an aggregate market value of $1,000,320.00. Fidelity Brokerage Services LLC is listed as the broker, and the approximate sale date is October 15, 2026. The security history includes prior ESPP purchases, dividend reinvestments, restricted-stock vesting and a stock-option exercise.

Key Figures

Common shares proposed for sale: 10,420 shares Aggregate market value: $1,000,320.00 Shares outstanding: 1,279,137,890 shares

3 metrics

Common shares proposed for sale 10,420 shares Proposed sale for Michael Marinaro

Aggregate market value $1,000,320.00 Proposed sale

Shares outstanding 1,279,137,890 shares Medtronic common stock

Key Terms

Rule 144, ESPP Purchase, Dividend Reinvestment, Restricted Stock Vesting, +1 more

5 terms

Rule 144 regulatory

"paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

ESPP Purchase financial

"03/29/2019 | ESPP Purchase"

Dividend Reinvestment financial

"07/31/2020 | Dividend Reinvestment"

Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.

Restricted Stock Vesting financial

"04/30/2021 | Restricted Stock Vesting"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Stock Option Exercise financial

"01/27/2025 | Stock Option Exercise"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MDT shares is Michael Marinaro proposing to sell?

Michael Marinaro is listed for a proposed sale of 10,420 Medtronic common shares, with an aggregate market value of $1,000,320.00. Fidelity Brokerage Services LLC is listed as the broker, and October 15, 2026, is the approximate sale date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/15/2026 - 05:00 PM EDT Accepted by SEC EDGAR 10/15/2026 - 05:00 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001984186
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Medtronic plc
SEC File Number	001-36820
Address of Issuer	BUILDING TWO PARKMORE BUSINESS PARK WEST GALWAY IRELAND H91 4K49
Phone	01135314381700
Name of Person for Whose Account the Securities are To Be Sold	Marinaro Michael
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	10420	1000320.00	1279137890	10/15/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/29/2019	ESPP Purchase	Issuer			161	03/29/2019	Cash
Common	06/28/2019	ESPP Purchase	Issuer			106	06/28/2019	Cash
Common	07/31/2020	Dividend Reinvestment	Issuer			1	07/31/2020	Cash
Common	10/19/2020	Dividend Reinvestment	Issuer			3	10/19/2020	Cash
Common	01/19/2021	Dividend Reinvestment	Issuer			3	01/19/2021	Cash
Common	04/19/2021	Dividend Reinvestment	Issuer			3	04/19/2021	Cash
Common	04/30/2021	Restricted Stock Vesting	Issuer			691	04/30/2021	Compensation
Common	07/19/2021	Dividend Reinvestment	Issuer			7	07/19/2021	Cash
Common	07/30/2021	Restricted Stock Vesting	Issuer			1200	07/30/2021	Compensation
Common	06/30/2022	ESPP Purchase	Issuer			125	06/30/2022	Cash
Common	03/03/2023	Restricted Stock Vesting	Issuer			620	03/03/2023	Compensation
Common	03/31/2023	ESPP Purchase	Issuer			252	03/31/2023	Cash
Common	04/17/2023	Dividend Reinvestment	Issuer			11	04/17/2023	Cash
Common	06/30/2023	ESPP Purchase	Issuer			42	06/30/2023	Cash
Common	07/17/2023	Dividend Reinvestment	Issuer			8	07/17/2023	Cash
Common	08/03/2023	Restricted Stock Vesting	Issuer			1352	08/03/2023	Compensation
Common	10/16/2023	Dividend Reinvestment	Issuer			23	10/16/2023	Cash
Common	01/16/2024	Dividend Reinvestment	Issuer			19	01/16/2024	Cash
Common	03/03/2024	Restricted Stock Vesting	Issuer			1077	03/03/2024	Compensation
Common	04/15/2024	Dividend Reinvestment	Issuer			30	04/15/2024	Cash
Common	07/15/2024	Dividend Reinvestment	Issuer			32	07/15/2024	Cash
Common	08/02/2024	Restricted Stock Vesting	Issuer			2099	08/02/2024	Compensation
Common	08/20/2024	Restricted Stock Vesting	Issuer			2154	08/20/2024	Compensation
Common	10/14/2024	Dividend Reinvestment	Issuer			61	10/14/2024	Cash
Common	01/13/2025	Dividend Reinvestment	Issuer			68	01/13/2025	Cash
Common	01/27/2025	Stock Option Exercise	Issuer			272	01/27/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	10/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/17/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Michael Marinaro
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)